fda bpc-157 category 2 bulk drug substance list has removed certain substances that were placed on the two and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of BPC-157 just got voted in
BPC 157 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank FDA to Remove 12 Popular Peptides from the Category 2 Do Not Compound List Frier Levitt FDA Peptide Update 2026: Removal from Do Not Compound List and What It Means for Pharmacies Is BPC 157 Legal in 2026? FDA Compounding Status Explained Peptide Therapy in Austin, TX Austin Plastic Surgeon Dr. Chuma
Pay in 4 interest-free payments of $5.53 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20


